Related Experiment Video
Updated: May 2, 2026

Tickling, a Technique for Inducing Positive Affect When Handling Rats
Published on: May 8, 2018
Dragging ras back in the ring
Andrew G Stephen1, Dominic Esposito1, Rachel K Bagni1
1Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, P.O. Box B, Frederick, MD 21702, USA.
Abstract:
Ras proteins play a major role in human cancers but have not yielded to therapeutic attack. Ras-driven cancers are among the most difficult to treat and often excluded from therapies. The Ras proteins have been termed "undruggable," based on failures from an era in which understanding of signaling transduction, feedback loops, redundancy, tumor heterogeneity, and Ras' oncogenic role was poor. Structures of Ras oncoproteins bound to their effectors or regulators are unsolved, and it is unknown precisely how Ras proteins activate their downstream targets. These knowledge gaps have impaired development of therapeutic strategies. A better understanding of Ras biology and biochemistry, coupled with new ways of targeting undruggable proteins, is likely to lead to new ways of defeating Ras-driven cancers.
Insights
Ras proteins are key drivers of human cancers but remain "undruggable" due to poor understanding of their complex biology. New therapeutic strategies targeting these difficult-to-treat cancers require deeper insights into Ras protein function.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Ras proteins are crucial in human cancers, yet effective therapies remain elusive.
- These proteins are considered "undruggable" due to historical limitations in understanding their complex signaling pathways, feedback loops, and role in tumor heterogeneity.
- Previous therapeutic failures stem from incomplete knowledge of Ras oncoprotein structures and their downstream target activation mechanisms.
Purpose of the Study:
- To highlight the significant role of Ras proteins in human cancers.
- To underscore the challenges and knowledge gaps hindering the development of effective Ras-targeted therapies.
- To advocate for enhanced understanding of Ras biology and biochemistry for novel therapeutic approaches.
Main Methods:
- Review of existing literature on Ras protein function in cancer.
- Analysis of historical therapeutic failures and their underlying causes.
- Identification of critical knowledge gaps in Ras signaling and protein interactions.
Main Results:
- Ras-driven cancers represent a significant and challenging clinical problem.
- Past attempts to target Ras proteins have been unsuccessful due to a poor grasp of their complex biological roles.
- Key knowledge gaps persist regarding Ras oncoprotein structures and their precise mechanisms of downstream target activation.
Conclusions:
- A deeper understanding of Ras biology and biochemistry is essential for overcoming therapeutic challenges.
- Novel strategies are needed to target previously undruggable proteins like Ras.
- Advancing research in Ras-driven cancers holds promise for developing new treatments for these difficult-to-treat malignancies.
Related Concept Videos
The Ras Gene
The Ras Gene
Ras is a...
Drag Force and Terminal Speed
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Cell Polarization by Rho Proteins
Radical Formation: Elimination

